CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 2 filers reported holding CALITHERA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $238,000 | -37.9% | 589,404 | +2.2% | 0.00% | – |
| Q4 2021 | $383,000 | -78.2% | 576,585 | -28.3% | 0.00% | – |
| Q3 2021 | $1,753,000 | +21.3% | 804,384 | +16.3% | 0.00% | – |
| Q2 2021 | $1,445,000 | -48.1% | 691,762 | -39.9% | 0.00% | – |
| Q1 2021 | $2,785,000 | -40.4% | 1,151,234 | +20.9% | 0.00% | -100.0% |
| Q4 2020 | $4,673,000 | +43.6% | 951,917 | +0.9% | 0.00% | 0.0% |
| Q3 2020 | $3,255,000 | -30.2% | 943,692 | +6.9% | 0.00% | 0.0% |
| Q2 2020 | $4,660,000 | +29.9% | 882,708 | +9.3% | 0.00% | 0.0% |
| Q1 2020 | $3,586,000 | -52.9% | 807,690 | -39.5% | 0.00% | 0.0% |
| Q4 2019 | $7,620,000 | +333.2% | 1,334,716 | +134.4% | 0.00% | – |
| Q3 2019 | $1,759,000 | -4.6% | 569,298 | +20.4% | 0.00% | – |
| Q2 2019 | $1,843,000 | -33.2% | 472,722 | +15.4% | 0.00% | -100.0% |
| Q1 2019 | $2,760,000 | -1.3% | 409,601 | -41.3% | 0.00% | – |
| Q4 2018 | $2,796,000 | +93.5% | 697,334 | +153.2% | 0.00% | – |
| Q3 2018 | $1,445,000 | +9.6% | 275,417 | +4.4% | 0.00% | – |
| Q2 2018 | $1,318,000 | -14.8% | 263,686 | +7.3% | 0.00% | -100.0% |
| Q1 2018 | $1,547,000 | -32.9% | 245,645 | -11.1% | 0.00% | 0.0% |
| Q4 2017 | $2,307,000 | -50.0% | 276,354 | -5.6% | 0.00% | -50.0% |
| Q3 2017 | $4,611,000 | +32.7% | 292,820 | +25.2% | 0.00% | +100.0% |
| Q2 2017 | $3,474,000 | +181.1% | 233,958 | +118.3% | 0.00% | 0.0% |
| Q1 2017 | $1,236,000 | +474.9% | 107,169 | +61.6% | 0.00% | – |
| Q4 2016 | $215,000 | +0.5% | 66,328 | +0.4% | 0.00% | – |
| Q3 2016 | $214,000 | +4.4% | 66,088 | +19.4% | 0.00% | – |
| Q2 2016 | $205,000 | -45.5% | 55,351 | -16.5% | 0.00% | – |
| Q1 2016 | $376,000 | -20.7% | 66,250 | +6.9% | 0.00% | – |
| Q4 2015 | $474,000 | +44.1% | 61,964 | +2.0% | 0.00% | – |
| Q3 2015 | $329,000 | -14.3% | 60,722 | +12.9% | 0.00% | – |
| Q2 2015 | $384,000 | -54.1% | 53,790 | +5.5% | 0.00% | – |
| Q1 2015 | $837,000 | -18.4% | 50,981 | +0.4% | 0.00% | -100.0% |
| Q4 2014 | $1,026,000 | – | 50,801 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,290,000 | 3.82% |
| BVF INC/IL | 7,452,331 | $16,246,000 | 0.63% |
| TSP Capital Management Group, LLC | 661,600 | $1,442,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,245 | $406,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 525,667 | $1,146,000 | 0.12% |
| Parkman Healthcare Partners LLC | 100,628 | $219,000 | 0.06% |
| FEDERATED HERMES, INC. | 6,668,978 | $14,539,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 133,700 | $291,000 | 0.02% |
| Ergoteles LLC | 274,805 | $599,000 | 0.02% |
| Seelaus Asset Management LLC | 16,150 | $35,000 | 0.02% |